SCHEMBL6202360

SCHEMBL6202360

Nc1c[c]cc(C(=O)O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.50
KDM4E B2RXH2 7/20 0.38
KMT2A Q03164 6/20 0.38
GFER P55789 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TDP1 Q9NUW8 5/20 0.36
ALDH1A1 P00352 5/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 4/20 0.36
THRB P10828 3/20 0.36
CYP3A4 P08684 3/20 0.36
CASP7 P55210 3/20 0.36
RECQL P46063 2/20 0.36
CASP1 P29466 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CASP6 P55212 2/20 0.36
PTPN1 P18031 2/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6198273 0.84 SELL (0.42) MMP2KDM4EKMT2ATDP1ALDH1A1
SCHEMBL5468565 0.77 SELL (0.48) KDM4EKMT2ATDP1ALDH1A1MAPT
SCHEMBL27810508 0.77 CASP7 (0.41) MMP2KDM4EKMT2AGFERRXFP1
SCHEMBL6199717 0.76 ALDH1A1 (0.47) KDM4EGFERTDP1ALDH1A1MAPT
SCHEMBL7410977 0.75
SCHEMBL6197026 0.74 AKR1C3 (0.50) KDM4EALDH1A1HSD17B10PTPN1HPGD
SCHEMBL27525268 0.74 TP53 (0.36) MMP2KDM4EKMT2ATDP1ALDH1A1
SCHEMBL6199994 0.74 ALDH1A1 (0.36) MMP2KDM4EKMT2ATDP1ALDH1A1
SCHEMBL5468861 0.74 KDM4E (0.50) MMP2KDM4EKMT2ATDP1ALDH1A1
SCHEMBL6199605 0.74 AKR1C2 (0.50) KDM4EKMT2ARXFP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
US-6011037-A Thiazole derivatives with phosphodiesterase-inhibiting action BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-01-04 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed